Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by love_minus_zeroon May 11, 2011 7:15pm

462 Views

Post# 18562725

RE: RE: RE: RE: Short Interest...

Rusty, one has to assume whoever is shorting TH believes they can exit with some ease, otherwise such a position on a poorly liquid stock would be foolish.
One would think we are still living in the 2008 meltdown with the daily movements on TH.
Who is going to be correct is the big question, the shorts, or the longs?
Unless the insiders are restricted we will be able to gauge where to be be their purchases of TH stock in the days and weeks ahead.
lmz

Bullboard Posts

This junior mining stock offers billions in market exposure